Derivatives of sobetirome
US-10870616-B2 · Dec 22, 2020 · US
2-methoxy-4-(3-(4-methoxyphenyl)prop-1-en-1-yl)phenol and preparation method therefor
US10125073B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10125073-B2 |
| Application number | US-201615556060-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 3, 2016 |
| Priority date | Mar 6, 2015 |
| Publication date | Nov 13, 2018 |
| Grant date | Nov 13, 2018 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Provided herein are 2-methoxy-4-(3-(4-methoxyphenyl)prop-1-en-1-yl)phenol having a novel structure capable of being used to prevent or treat all diseases associated with NF-κB, IKK and STAT3, and a method of preparing the same.
First claim
Opening claim text (preview).
What is claimed is: 1. 2-Methoxy-4-(3-(4-methoxyphenyl)prop-1-en-1-yl)phenol represented by the following Formula 1: 2. A method of preparing 2-methoxy-4-(3-(4-methoxyphenyl)prop-1-en-1-yl)phenol represented by Formula 1, which is prepared by allowing a compound of Formula 2 to react with a compound of Formula 3, as represented by the following Scheme 1: wherein X represents a halogen element. 3. The method of claim 2 , wherein the X is F, Cl, I, or Br. 4. The method of claim 2 , wherein the reaction is carried out in the presence of a palladium catalyst and a base. 5. The method of claim 2 , wherein the reaction is carried out by additionally adding a ligand comprising a phosphine or phosphite.
Assignees
Inventors
Classifications
- C07C39/07Primary
containing only methyl groups, e.g. cresols, xylenols · CPC title
- C07C41/24Primary
by elimination of halogens, e.g. elimination of HCl · CPC title
by substitution of halogen · CPC title
by increasing the number of carbon atoms, e.g. by oligomerisation · CPC title
- C07C43/23Primary
containing hydroxy or O-metal groups · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US10125073B2 cover?
- Provided herein are 2-methoxy-4-(3-(4-methoxyphenyl)prop-1-en-1-yl)phenol having a novel structure capable of being used to prevent or treat all diseases associated with NF-κB, IKK and STAT3, and a method of preparing the same.
- Who is the assignee on this patent?
- Chungbuk National Univ Industry—Academic Cooperation Foundation, Nat Univ Chungbuk Ind Acad Coop Found
- What technology area does this patent fall under?
- Primary CPC classification C07C39/07. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Nov 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).